What is the Regulatory Process in Cancer Treatment?
The regulatory process in cancer treatment involves a series of steps designed to ensure the safety, efficacy, and quality of new cancer therapies. This process is governed by regulatory agencies such as the FDA (Food and Drug Administration) in the United States, the EMA (European Medicines Agency) in Europe, and other national regulatory bodies. These agencies evaluate clinical trial data, manufacturing processes, and post-marketing surveillance to approve or reject new treatments.
